Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
170,107,714
-
Number of holders
-
187
-
Total 13F shares, excl. options
-
98,249,994
-
Shares change
-
+896,261
-
Total reported value, excl. options
-
$4,115,830,564
-
Value change
-
+$65,989,817
-
Put/Call ratio
-
1.06%
-
Number of buys
-
90
-
Number of sells
-
-97
-
Price
-
$41.88
Significant Holders of ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value (ACAD) as of Q2 2015
239 filings reported holding ACAD - ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value as of Q2 2015.
ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value (ACAD) has 187 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 98,249,994 shares
of 170,107,714 outstanding shares and own 57.76% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (20,481,442 shares), FMR LLC (15,044,613 shares), PRICE T ROWE ASSOCIATES INC /MD/ (5,632,514 shares), VANGUARD GROUP INC (5,302,962 shares), OPPENHEIMER FUNDS INC (3,779,798 shares), Capital World Investors (3,421,756 shares), BlackRock Fund Advisors (3,207,084 shares), JANUS CAPITAL MANAGEMENT LLC (3,020,512 shares), JENNISON ASSOCIATES LLC (2,521,324 shares), and FRANKLIN RESOURCES INC (2,480,553 shares).
This table shows the top 187 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.